REVAPRICK: Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children
Study Details
Study Description
Brief Summary
Main objective :
Evaluate the effect of using a virtual reality mask during the blood test and pricks tests in allergic children aged from 7 to 13 years.
Hypothesis :
Using virtual reality mask during blood test and pricks tests for allergic kids from 7 to 13 would reduce anxiety and pain
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Investigation of food or respiratory allergy is based on prick tests and serum specific immunoglobulin E assays. The nurse often controls the blood test pain but during the skin tests, many children cry, feeling both fear and pain. This traumatic experience will in most cases be repeated during the child's allergic follow-up.
To date, there are few effective means of limiting anxiety and pain associated with prick tests and therefore little research work on this subject.
Immersion in virtual reality (VR) seems to be an interesting way of distraction for children from 7 to 13 years needing this treatment. Indeed, it makes it possible to saturate the sensorially of the child thus reducing the nociceptive perceptions and the anxiety. The choice of VR mask with pediatric program specific seems interesting for this children This is a randomized, open-label, two-armed parallel, multicenter therapeutic trial comparing an analgesic strategy using authorized medical devices (conventional strategy) with a virtual reality mask distraction technique for allergics tests in children from 7 to 13 years old hospitalized in the pediatric consultation of Clermont Ferrand University Hospital and in the day hospital of Saint-Etienne University Hospital
The control arm is the local anesthetic cream (for the blood test) arm with distraction from nurse/parents +/-anesthesic and anxiolytic gas and the experimental arm is the local anesthetic cream + virtual reality mask distraction
The nurse informs and obtains the consent of the child and his parents. Then she measures child's pain and anxiety before the care, during the blood test, at the third prick test and immediately after the care.
She also notes the anxiety of the parents before and after the care. Finally, the satisfaction of the child, parents, nurses will be collected at the end of the care.
After statistical analysis of these two arms, it will be possible to determine the value of the virtual reality mask to reduce the child's pain and anxiety during the pricks tests.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: standard Use local anesthesic cream + nurse or parents distraction +/- anesthesic or anxiolytic gas |
Other: control arm
usual process
|
| Experimental: virtual reality Use local anesthesic cream and virtual reality mask |
Device: Virtual reality mask
virtual reality mask Deepsen® with age-appropriate software Birdy®
|
Outcome Measures
Primary Outcome Measures
- children's pain hetero-evaluation [during blood test]
children's pain evaluation by the nurse with the visual analog scale quote from 0 to 10, 10=worst score
- children's pain hetero-evaluation [during procedure (prick test)]
children's pain evaluation by the nurse with the visual analog scale from 0 to 10, 10= worst score
- children's pain self-evaluation [5 min after the care]
self evaluation of children's pain with the visial analog scale in vertical position quote from 0 to 10, 10=worst score
Secondary Outcome Measures
- change from baseline children's anxiety at just after the care [before the care and 5 min after the care]
self-evaluation of children's anxiety with the scale "child fear scale" quote from 0 to 4, 4= worst score
- children's anxiety hetero evaluation [during blood test]
children's anxiety evaluation by the nurse with the scale "child fear scale" quote from 0 to 4, 4= worst score
- children's anxiety hetero evaluation [during procedure (prick tests)]
children's anxiety evaluation by the nurse with the scale "child fear scale" quote from 0 to 4, 4= worst score
- change from baseline parents' anxiety at just after the care [before the care and 5 min after the care]
self-evaluation of parents' anxiety with the numerical scale quote from 1 to 10, 10= worst score
- evaluation of the care [5 min after the care]
satisfaction of the care for children, parents and nurses with satisfaction questionnaire for children : a score from 1 to 3 (3=best score, very satisfied) for parents with a score from 1 to 5 (5= best score, very satisfied) and for nurse with a score from 1 to 5 (5= best score, very satisfied)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Children from 7 to 13 years old requiring blood test and prick tests in pediatric consultation at the Clermont-Ferrand University Hospital and in the pediatric's day hospital at the Saint-Etienne University Hospital
-
Subjects and their parents who were informed about the study and gave informed consent
-
Enrollment in the Social Security system
-
Children and parents able to use the self-report scales proposed in the study
Exclusion Criteria:
Children from 7 to 13 :
-
presenting a contraindication to the use of the virtual reality mask: heart disease, epilepsy, psychiatric illness (major anxiety, post-traumatic stress disorder)
-
Having a modification of pain's integration (spina bifida for example)
-
Having received an analgesic before the care
-
Requiring contact isolation
-
With a history of seizures or motion sickness
-
Refusal of the parents and/or the child
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHU de Clermont-Ferrand | Clermont-Ferrand | France | 63000 | |
| 2 | CHU de Saint Etienne | Saint-Étienne | France | 42000 |
Sponsors and Collaborators
- University Hospital, Clermont-Ferrand
Investigators
- Principal Investigator: Alexandra USCLADE, University Hospital, Clermont-Ferrand
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- GIRCI 2020 USCLADE
- 2021-A02125-36